Skip to main content

ObsEva SA

OBSVDelisted Mar 27, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001685316

ObsEva SA was delisted on Mar 27, 2023; its insiders filed their last Form 4 on Apr 11, 2023; 27 institutions reported holding it in 13F filings for Q4 2022, worth $1.89M in total; no superinvestor held it.

Q3 2021 vs. Q2 2021

How the institutions holding ObsEva SA changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of OBSV: Q2 2021 compared with Q3 2021
MeasureQ2 2021Of which not filed for Q3 2021Q3 2021Change
Holders44141−2
Shares18.3M211.8K17.5M−579.1K (−3.2%)
Value$52.6M$642.0K$54.4M+$2.37M (+4.6%)

1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (5)

Institutions that held ObsEva SA at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to OBSV in Q3 2021
InstitutionSharesValue% of portfolio
Pictet Asset Management SA226,456$704.0K0.00%
Toroso Investments, LLC63,844$199.0K0.01%
Gsa Capital Partners LLP32,036$100.0K0.01%
Optiver Holding B.V.19,551$62.0K0.00%
Advisor Group Holdings, Inc.5,000$16.0K0.00%

Sold out (7)

Institutions that held ObsEva SA at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of OBSV in Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
Jump Financial, LLC103,400$313.0K
Renaissance Technologies LLC81,000$245.0K
Marshall Wace, LLP29,778$90.0K
DCF Advisers, LLC26,500$80.0K
Virtu Financial LLC25,964$79.0K
Concord Wealth Partners400$1.00K
Salem Investment Counselors Inc6$0

Not filed for Q3 2021 yet (1)

Institutions that held ObsEva SA at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding OBSV in Q2 2021 that haven't filed for Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
Pictet Asset Management Ltd211,840$642.0K